Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013 (2013), Article ID 458989, 10 pages
http://dx.doi.org/10.1155/2013/458989
Research Article

Characterization of Schizophrenia Adverse Drug Interactions through a Network Approach and Drug Classification

1Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN 37203, USA
2Center for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, TN 37232, USA
3Mental Health Service Line, Washington VA Medical Center, 50 Irving St. NW, Washington, DC 20422, USA
4Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, VA 23298, USA
5Department of Psychiatry, Vanderbilt University School of Medicine, Nashville, TN 37212, USA
6Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA

Received 5 July 2013; Accepted 8 August 2013

Academic Editor: Bairong Shen

Copyright © 2013 Jingchun Sun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [7 citations]

The following is the list of published articles that have cited the current article.

  • Melike Ceyhan Balci Sengul, Filiz Karadag, Cem Sengul, Kamuran Karakulah, Ozgur Kalkanci, and Hasan Herken, “Risk of Psychotropic Drug Interactions in Real World Settings: a Pilot Study in Patients with Schizophrenia and Schizoaffective Disorder,” Klinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology, vol. 24, no. 3, pp. 235–247, 2014. View at Publisher · View at Google Scholar
  • Jingchun Sun, Liang-Chin Huang, Hua Xu, and Zhongming Zhao, “Network-Assisted Prediction of Potential Drugs for Addiction,” BioMed Research International, vol. 2014, pp. 1–9, 2014. View at Publisher · View at Google Scholar
  • Liang-Chin Huang, Ergin Soysal, W. Jim Zheng, Zhongming Zhao, Hua Xu, and Jingchun Sun, “A weighted and integrated drug-target interactome: drug repurposing for schizophrenia as a use case,” Bmc Systems Biology, vol. 9, 2015. View at Publisher · View at Google Scholar
  • Alma Genis, Carlos Alfonso Tovilla-Zárate, Thelma Beatriz González-Castro, María Elena de la O de la O, Humberto Nicolini, María Conchita Ocaña-Zurita, Isela E. Juárez-Rojop, and María Lilia López-Narváez, “Potential drug–drug interaction in Mexican patients with schizophrenia,” International Journal of Psychiatry in Clinical Practice, vol. 20, no. 4, pp. 249–253, 2016. View at Publisher · View at Google Scholar
  • Samamon Khemmarat, and Lixin Gao, “Predictive and Personalized Drug Query System,” IEEE Journal of Biomedical and Health Informatics, vol. 21, no. 4, pp. 1146–1155, 2017. View at Publisher · View at Google Scholar
  • Lei Gao, Shuo Feng, Zhao-yuan Liu, Jiu-qiang Wang, Ke-ke Qi, and Kai Wang, “A computational network analysis based on targets of antipsychotic agents,” Schizophrenia Research, 2017. View at Publisher · View at Google Scholar
  • Vinicius Ricardo Acquaro, Diego Soares Domingues, and Maria Eugênia Costa Queiroz, “Column switching UHPLC-MS/MS with restricted access material for the determination of CNS drugs in plasma samples,” Bioanalysis, vol. 9, no. 6, pp. 555–568, 2017. View at Publisher · View at Google Scholar